TUR is both diagnostic and therapeutic, and findings or outcomes can dictate further disease management. Restaging TUR in patients with T1 tumors is an important component of management. Intravesical ...
Management of Disseminated Nonseminomatous Germ Cell Tumors With Risk-Based Chemotherapy Followed by Response-Guided Postchemotherapy Surgery Approximately 30% to 40% patients with a superficial ...
Bladder cancer is a heterogeneous disease. Non–muscle-invasive bladder cancer embraces a spectrum of tumors with varying degrees of clinical behavior. Transurethral resection remains the surgical ...
You've been diagnosed with bladder cancer that has not invaded the muscle layer -- i.e., non-muscle invasive bladder cancer (NMIBC), also called superficial bladder cancer. Although the cure rate with ...
Techno-Science.net on MSN
🎯 Cancer: this innovative device eliminates resistant tumors
The treatment of bladder cancer could see a major advancement thanks to an innovative drug delivery approach. This targeted method specifically attacks tumors resistant to conventional ...
In this segment of Case-by-Case, Dr Petros Grivas applies NIAGARA data to a bladder cancer case, examining the role of ctDNA in perioperative decisions.
SAN FRANCISCO—Intravesical gemcitabine may be a safe and effective treatment for superficial bladder cancer, data suggest. Australian investigators tested the treatment in a Phase II trial that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback